Dr. Reddy's sells Tennessee antibiotic manufacturing site

Dr. Reddy's sells Tennessee antibiotic manufacturing site


Dr. Reddy's Laboratories antibiotic manufacturing site in Bristol, Tennessee, has been sold to Neopharma, along with all issued and outstanding membership interests and related assets. According to the multinational company, it sold the Tennessee facility as step towards its goal of optimizing global cost structures.



from Biotech News